These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


739 related items for PubMed ID: 15055140

  • 21. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
    Sugar AM.
    Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A, Prentice AG.
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The place for itraconazole in treatment.
    Maertens J, Boogaerts M.
    J Antimicrob Chemother; 2005 Sep 15; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [Abstract] [Full Text] [Related]

  • 29. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML.
    J Microbiol Immunol Infect; 2009 Apr 15; 42(2):141-7. PubMed ID: 19597646
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R, Görgün O, Ayan I, Gürler N, Akici F, Töreci K.
    Med Pediatr Oncol; 2001 Apr 15; 36(4):434-41. PubMed ID: 11260566
    [Abstract] [Full Text] [Related]

  • 32. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
    Slobbe L, Waal Lv, Jongman LR, Lugtenburg PJ, Rijnders BJ.
    Eur J Cancer; 2009 Nov 15; 45(16):2810-7. PubMed ID: 19647995
    [Abstract] [Full Text] [Related]

  • 33. [Antibiotic therapy in leukopenia].
    Böhme A, Shah PM, Stille W, Hoelzer D.
    Praxis (Bern 1994); 1998 Sep 02; 87(36):1120-5. PubMed ID: 9782739
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC.
    Mycoses; 1999 Sep 02; 42 Suppl 2():121-4. PubMed ID: 10865918
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D, Buadi FK, McClune B.
    Pharmacotherapy; 2008 Jan 02; 28(1):58-63. PubMed ID: 18154475
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients.
    Rieger CT, Ostermann H.
    Mycoses; 2008 Jan 02; 51 Suppl 1():31-4. PubMed ID: 18471159
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 37.